Quanterix Corporation (QTRX): Price and Financial Metrics
GET POWR RATINGS... FREE!
QTRX POWR Grades
- Growth is the dimension where QTRX ranks best; there it ranks ahead of 65.54% of US stocks.
- The strongest trend for QTRX is in Stability, which has been heading up over the past 179 days.
- QTRX's current lowest rank is in the Momentum metric (where it is better than 15.23% of US stocks).
QTRX Stock Summary
- QTRX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 13.42% of US stocks.
- With a year-over-year growth in debt of 101.46%, QUANTERIX CORP's debt growth rate surpasses 88.16% of about US stocks.
- In terms of twelve month growth in earnings before interest and taxes, QUANTERIX CORP is reporting a growth rate of 77.54%; that's higher than 83.69% of US stocks.
- If you're looking for stocks that are quantitatively similar to QUANTERIX CORP, a group of peers worth examining would be ROVR, TRUE, VCYT, PRCH, and EVCM.
- QTRX's SEC filings can be seen here. And to visit QUANTERIX CORP's official web site, go to www.quanterix.com.
QTRX Valuation Summary
- In comparison to the median Healthcare stock, QTRX's price/sales ratio is 10.64% lower, now standing at 4.2.
- QTRX's EV/EBIT ratio has moved up 11.9 over the prior 64 months.
Below are key valuation metrics over time for QTRX.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| QTRX | 2023-03-17 | 4.2 | 1.2 | -4.6 | -1.4 |
| QTRX | 2023-03-16 | 4.3 | 1.3 | -4.7 | -1.5 |
| QTRX | 2023-03-15 | 4.2 | 1.2 | -4.6 | -1.4 |
| QTRX | 2023-03-14 | 4.3 | 1.3 | -4.7 | -1.5 |
| QTRX | 2023-03-13 | 4.3 | 1.3 | -4.7 | -1.5 |
| QTRX | 2023-03-10 | 4.2 | 1.2 | -4.6 | -1.5 |
QTRX's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- QTRX has a Quality Grade of D, ranking ahead of 13.4% of graded US stocks.
- QTRX's asset turnover comes in at 0.276 -- ranking 59th of 75 Measuring and Control Equipment stocks.
- 500 - Internal server error
The table below shows QTRX's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.276 | 0.603 | -0.474 |
| 2021-03-31 | 0.318 | 0.590 | -0.489 |
| 2020-12-31 | 0.398 | 0.558 | -0.511 |
| 2020-09-30 | 0.397 | 0.525 | -0.611 |
| 2020-06-30 | 0.352 | 0.434 | -1.038 |
| 2020-03-31 | 0.385 | 0.460 | -1.276 |
QTRX Price Target
For more insight on analysts targets of QTRX, see our QTRX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $76.00 | Average Broker Recommendation | 1.42 (Moderate Buy) |
QTRX Stock Price Chart Interactive Chart >
QTRX Price/Volume Stats
| Current price | $10.58 | 52-week high | $31.33 |
| Prev. close | $10.71 | 52-week low | $6.31 |
| Day low | $10.27 | Volume | 203,011 |
| Day high | $10.74 | Avg. volume | 318,244 |
| 50-day MA | $12.93 | Dividend yield | N/A |
| 200-day MA | $12.75 | Market Cap | 394.09M |
Quanterix Corporation (QTRX) Company Bio
Quanterix Corporation develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and Asia Pacific. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and SR-X system that supports the detection capability of approximately six biomarkers per test. The company’s products also comprise kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, assay development, and custom development services. Quanterix Corporation primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was founded in 2007 and is based in Lexington, Massachusetts.
Latest QTRX News From Around the Web
Below are the latest news stories about QUANTERIX CORP that investors may wish to consider to help them evaluate QTRX as an investment opportunity.
Quanterix to Participate in Barclays Global Healthcare ConferenceBILLERICA, Mass., March 08, 2023--Quanterix announced that CEO Masoud Toloue will present at Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 4:35 p.m., EDT. |
Quanterix Corporation (NASDAQ:QTRX) Q4 2022 Earnings Call TranscriptQuanterix Corporation (NASDAQ:QTRX) Q4 2022 Earnings Call Transcript March 6, 2023 Operator: Good day, and thank you for standing by. Welcome to the Quanterix Corporation Q4 2022 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. . Please be advised that today’s […] |
Q4 2022 Quanterix Corp Earnings CallQ4 2022 Quanterix Corp Earnings Call |
Quanterix Corporation (QTRX) Reports Q4 Loss, Misses Revenue EstimatesQuanterix Corporation (QTRX) delivered earnings and revenue surprises of 5.66% and 1.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? |
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with ExpectationsBILLERICA, Mass., March 06, 2023--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced financial results for the fourth quarter and twelve months ended December 31, 2022. |
QTRX Price Returns
| 1-mo | -10.11% |
| 3-mo | -17.98% |
| 6-mo | 24.91% |
| 1-year | -62.94% |
| 3-year | -29.09% |
| 5-year | -34.61% |
| YTD | -23.61% |
| 2022 | -67.33% |
| 2021 | -8.82% |
| 2020 | 96.78% |
| 2019 | 29.06% |
| 2018 | -14.72% |
Continue Researching QTRX
Want to see what other sources are saying about Quanterix Corp's financials and stock price? Try the links below:Quanterix Corp (QTRX) Stock Price | Nasdaq
Quanterix Corp (QTRX) Stock Quote, History and News - Yahoo Finance
Quanterix Corp (QTRX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...